Formulation, characterisation and comparison of different raloxifene hydrochloride loaded lipid-polymer hybrid nanoparticles

被引:1
作者
Mahmood S. [1 ]
Phey T.C. [1 ]
Kheng L.S. [1 ]
Chen K.P. [1 ]
Mandal U.K. [2 ]
机构
[1] Department of Pharmaceutical Engineering, Faculty of Chemical and Process Engineering Technology, University Malaysia Pahang, Gambang
[2] Department of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University (MRSPTU), Bathinda
关键词
Lipid-polymeric hybrid nanoparticle; LPHNP; Pharmacokinetic release modelling; Raloxifene; Release study;
D O I
10.1504/IJNBM.2020.112224
中图分类号
学科分类号
摘要
This study aims to formulate raloxifene loaded lipid-polymeric hybrid nanoparticles (LPHNPs) and the comparison of their properties. Three LPHNPs, each with phosphatidylcholine-lipid (PCL) as bilayer-formingmembrane with three different polymers like sodium alginate, chitosan and poly(lactic-co-glycolic-acid) were prepared by nanoprecipitation, solvent injection and emulsion solvent evaporation, respectively. Results showed that the prepared formulations were spherical-shaped with a heterogeneity. Surface morphology was viewed using a scanning electron microscopy (SEM). A high entrapment efficiency (>70%) with a sustained and pH dependent drug release profile for 24 h was observed and evaluated using mathematical kinetic modelling. Fourier transform infrared spectroscopy was used to confirm successful entrapment of raloxifene after evaluating the interaction and compatibility of the excipients used. Whereas, differential scanning calorimetry and X-ray diffraction revealed the transformation of raloxifene into an amorphous form. In conclusion, these hybrid nanoparticles provide a promising approach for oral delivery of raloxifene. © 2020 Inderscience Enterprises Ltd.
引用
收藏
页码:123 / 141
页数:18
相关论文
共 43 条
[1]  
Ascenso A., Salgado A., Euleterio C., Praca F.G., Bentley M.V.L.B., Marques H.C., Simoes S., In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles, European Journal of Pharmaceutics and Biopharmaceutics, 88, 1, pp. 48-55, (2014)
[2]  
Baghbani F., Moztarzadeh F., Mohandesi J.A., Yazdian F., Mokhtari-Dizaji M., Hamedi S., Formulation design, preparation and characterization of multifunctional alginate stabilized nanodroplets, International Journal of Biological Macromolecules, 89, pp. 550-558, (2016)
[3]  
Bhatia S., Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications, Natural Polymer Drug Delivery Systems, pp. 33-93, (2016)
[4]  
Cheow W.S., Hadinoto K., Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles, Colloids and Surfaces B: Biointerfaces, 85, 2, pp. 214-220, (2011)
[5]  
Dash S., Murthy P.N., Nath L., Chowdhury P., Kinetic modeling on drug release from controlled drug delivery systems, Acta Poloniae Pharmaceutica, 67, 3, pp. 217-223, (2010)
[6]  
Date T., Nimbalkar V., Kamat J., Mittal A., Mahato R.I., Chitkara D., Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics, Journal of Controlled Release, 271, pp. 60-73, (2018)
[7]  
Dehaini D., Fang R.H., Luk B.T., Pang Z., Hu C.M.J., Kroll A.V., Yu C.L., Gao W., Zhang L., Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery, Nanoscale, 8, 30, pp. 14411-14419, (2016)
[8]  
Dong Y., Feng S.S., Poly (D, L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy, International journal of pharmaceutics, 342, 1-2, pp. 208-214, (2007)
[9]  
Dragicevic-Curic N., Scheglmann D., Albrecht V., Fahr A., Development of liposomes containing ethanol for skin delivery of temoporfin: Characterization and in vitro penetration studies, Colloids and Surfaces B: Biointerfaces, 74, 1, pp. 114-122, (2009)
[10]  
Geszke-Moritz M., Moritz M., Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies, Materials Science and Engineering: C, 68, pp. 982-994, (2016)